bioRxivBiophysics
Enhancing generating and collecting efficiency of single particle upconverting luminescence at low-level power excitation
Abstract
Upconverting luminescent nanoparticles are photostable, non-blinking, and low chemically toxic fluorophores that are emerging as promising fluorescent probe at single-molecule level. High luminescence intensity upconversion nanoparticles (UCNPs) is achieved with highly doped rare-earth ions co-doped (20% Yb3+) using high excitation power (>2.5 MW/cm2). However, such particles are inadequate for in-vitro live-cell imaging and single-particle tracking since high excitation power can cause photodamage. Here, we compared UCNPs luminescence intensities with different dopants concentrations and presented a more efficient ([~]7x) UCNPs at low excitation power by increasing the concentrations of Yb3+ and Tm3+ dopants (NaYF4: 60% Yb3+, 8% Tm3+) and adding a core-shell structure.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Porous upconversion nanostructures as bimodal biomedical imaging contrast agents
- Poor man's two photon imaging: Scanning Laser Upconversion Microscopy
Cecilia Sorbello, Roberto Etchenique·bioRxiv·May 17, 2017
- Intracellular photoswitchable neuropharmacology driven by luminescence from upconverting nanoparticles.
Jun Wei Zhao, Graham C. R. Ellis‐Davies·Chemical CommunicationsPeer-reviewed·Jan 1, 2020
- Simultaneous Optimization of Excitation Wavelength and Emission Window for Semiconducting Polymer Nanoparticles to Improve Imaging Quality
- The theoretical molecular weight of NaYF4:RE upconversion nanoparticles
L. E. MacKenzie, J. A. Goode, … P. A. Millner·bioRxiv·Sep 8, 2017
- pH-responsive upconversion mesoporous silica nanospheres for combined multimodal diagnostic imaging and targeted photodynamic and photothermal cancer therapy
L. Palanikumar, M. Kalmouni, … M. Magzoub·bioRxiv·May 22, 2023